493 related articles for article (PubMed ID: 25896862)
1. Impact of a magnetic resonance imaging-guided treat-to-target strategy on disease activity and progression in patients with rheumatoid arthritis (the IMAGINE-RA trial): study protocol for a randomized controlled trial.
Møller-Bisgaard S; Hørslev-Petersen K; Ejbjerg BJ; Boesen M; Hetland ML; Christensen R; Møller J; Krogh NS; Stengaard-Pedersen K; Østergaard M
Trials; 2015 Apr; 16():178. PubMed ID: 25896862
[TBL] [Abstract][Full Text] [Related]
2. Effect of Magnetic Resonance Imaging vs Conventional Treat-to-Target Strategies on Disease Activity Remission and Radiographic Progression in Rheumatoid Arthritis: The IMAGINE-RA Randomized Clinical Trial.
Møller-Bisgaard S; Hørslev-Petersen K; Ejbjerg B; Hetland ML; Ørnbjerg LM; Glinatsi D; Møller J; Boesen M; Christensen R; Stengaard-Pedersen K; Madsen OR; Jensen B; Villadsen JA; Hauge EM; Bennett P; Hendricks O; Asmussen K; Kowalski M; Lindegaard H; Nielsen SM; Bliddal H; Krogh NS; Ellingsen T; Nielsen AH; Balding L; Jurik AG; Thomsen HS; Østergaard M
JAMA; 2019 Feb; 321(5):461-472. PubMed ID: 30721294
[TBL] [Abstract][Full Text] [Related]
3. A double-blind, randomized controlled trial to compare the effect of biannual peripheral magnetic resonance imaging, radiography and standard of care disease progression monitoring on pharmacotherapeutic escalation in rheumatoid and undifferentiated inflammatory arthritis: study protocol for a randomized controlled trial.
Tavares R; Beattie KA; Bensen WG; Bobba RS; Cividino AA; Finlay K; Goeree R; Hart LE; Jurriaans E; Larche MJ; Parasu N; Tarride JE; Webber CE; Adachi JD
Trials; 2014 Jul; 15():268. PubMed ID: 24997587
[TBL] [Abstract][Full Text] [Related]
4. Association of bone edema with the progression of bone erosions quantified by hand magnetic resonance imaging in patients with rheumatoid arthritis in remission.
Lisbona MP; Pàmies A; Ares J; Almirall M; Navallas M; Solano A; Maymó J
J Rheumatol; 2014 Aug; 41(8):1623-9. PubMed ID: 24986851
[TBL] [Abstract][Full Text] [Related]
5. MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA).
Hetland ML; Ejbjerg B; Hørslev-Petersen K; Jacobsen S; Vestergaard A; Jurik AG; Stengaard-Pedersen K; Junker P; Lottenburger T; Hansen I; Andersen LS; Tarp U; Skjødt H; Pedersen JK; Majgaard O; Svendsen AJ; Ellingsen T; Lindegaard H; Christensen AF; Vallø J; Torfing T; Narvestad E; Thomsen HS; Ostergaard M;
Ann Rheum Dis; 2009 Mar; 68(3):384-90. PubMed ID: 18388160
[TBL] [Abstract][Full Text] [Related]
6. Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progression.
Brown AK; Quinn MA; Karim Z; Conaghan PG; Peterfy CG; Hensor E; Wakefield RJ; O'Connor PJ; Emery P
Arthritis Rheum; 2006 Dec; 54(12):3761-73. PubMed ID: 17133543
[TBL] [Abstract][Full Text] [Related]
7. Predictors of joint damage progression and stringent remission in patients with established rheumatoid arthritis in clinical remission.
Møller-Bisgaard S; Georgiadis S; Hørslev-Petersen K; Ejbjerg B; Hetland ML; Ørnbjerg LM; Glinatsi D; Møller J; Boesen M; Stengaard-Pedersen K; Madsen OR; Jensen B; Villadsen JA; Hauge EM; Bennett P; Hendricks O; Asmussen K; Kowalski M; Lindegaard H; Bliddal H; Krogh NS; Ellingsen T; Nielsen AH; Balding L; Jurik AG; Thomsen HS; Østergaard M
Rheumatology (Oxford); 2021 Jan; 60(1):380-391. PubMed ID: 32929463
[TBL] [Abstract][Full Text] [Related]
8. Effect of initiating biologics compared to intensifying conventional DMARDs on clinical and MRI outcomes in established rheumatoid arthritis patients in clinical remission: Secondary analyses of the IMAGINE-RA trial.
Møller-Bisgaard S; Hørslev-Petersen K; Ejbjerg B; Hetland ML; Christensen R; Ørnbjerg LM; Glinatsi D; Møller JM; Boesen M; Stengaard-Pedersen K; Madsen OR; Jensen B; Villadsen JA; Hauge EM; Bennett P; Hendricks O; Asmussen K; Kowalski M; Lindegaard H; Bliddal H; Krogh NS; Ellingsen T; Nielsen AH; Larsen L; Jurik AG; Thomsen HS; Østergaard M
Scand J Rheumatol; 2022 Jul; 51(4):268-278. PubMed ID: 34474649
[TBL] [Abstract][Full Text] [Related]
9. MRI evidence of persistent joint inflammation and progressive joint damage despite clinical remission during treatment of early rheumatoid arthritis.
Forslind K; Svensson B
Scand J Rheumatol; 2016; 45(2):99-102. PubMed ID: 26313244
[TBL] [Abstract][Full Text] [Related]
10. Novel optical spectral transmission (OST)-guided versus conventionally disease activity-guided treatment: study protocol of a randomized clinical trial on guidance of a treat-to-target strategy for early rheumatoid arthritis.
Besselink NJ; Westgeest AAA; Klaasen R; Gamala M; van Woerkom JM; Tekstra J; Verhoeven MMA; Van Spil WE; Lafeber FPJG; Marijnissen ACA; Van Laar JM; Jacobs JWG
Trials; 2019 Apr; 20(1):226. PubMed ID: 30999969
[TBL] [Abstract][Full Text] [Related]
11. Long-term efficacy of a 2-year MRI treat-to-target strategy on disease activity and radiographic progression in patients with rheumatoid arthritis in clinical remission: 5-year follow-up of the IMAGINE-RA randomised trial.
Møller-Bisgaard S; Hørslev-Petersen K; Ørnbjerg LM; Ejbjerg B; Hetland ML; Møller JM; Nielsen SM; Glinatsi D; Boesen M; Stengaard-Pedersen K; Madsen OR; Jensen B; Villadsen JA; Hauge EM; Hendricks O; Lindegaard H; Krogh NS; Jurik AG; Thomsen H; Christensen R; Østergaard M
RMD Open; 2024 Mar; 10(1):. PubMed ID: 38490697
[TBL] [Abstract][Full Text] [Related]
12. Joint damage in rheumatoid arthritis progresses in remission according to the Disease Activity Score in 28 joints and is driven by residual swollen joints.
Aletaha D; Smolen JS
Arthritis Rheum; 2011 Dec; 63(12):3702-11. PubMed ID: 21953215
[TBL] [Abstract][Full Text] [Related]
13. Anti-cyclic citrullinated peptide antibodies, 28-joint Disease Activity Score, and magnetic resonance imaging bone oedema at baseline predict 11 years' functional and radiographic outcome in early rheumatoid arthritis.
Hetland ML; Østergaard M; Stengaard-Pedersen K; Junker P; Ejbjerg B; Jacobsen S; Ellingsen T; Lindegaard H; Pødenphant J; Vestergaard A; Jurik AG; Krogh NS; Hørslev-Petersen K;
Scand J Rheumatol; 2019 Jan; 48(1):1-8. PubMed ID: 30101636
[TBL] [Abstract][Full Text] [Related]
14. ACR/EULAR Definitions of Remission Are Associated with Lower Residual Inflammatory Activity Compared with DAS28 Remission on Hand MRI in Rheumatoid Arthritis.
Lisbona MP; Solano A; Ares J; Almirall M; Salman-Monte TC; Maymó J
J Rheumatol; 2016 Sep; 43(9):1631-6. PubMed ID: 27370881
[TBL] [Abstract][Full Text] [Related]
15. Joint damage progression in patients with rheumatoid arthritis in clinical remission: do biologics perform better than synthetic antirheumatic drugs?
Ciubotariu E; Gabay C; Finckh A;
J Rheumatol; 2014 Aug; 41(8):1576-82. PubMed ID: 25028383
[TBL] [Abstract][Full Text] [Related]
16. Silent progression in patients with rheumatoid arthritis: is DAS28 remission an insufficient goal in RA? Results from the German Remission-plus cohort.
Sewerin P; Vordenbaeumen S; Hoyer A; Brinks R; Buchbender C; Miese F; Schleich C; Klein S; Schneider M; Ostendorf B
BMC Musculoskelet Disord; 2017 Apr; 18(1):163. PubMed ID: 28420375
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow oedema predicts structural progression in a 1-year follow-up of 85 patients with RA in remission or with low disease activity with low-field MRI.
Gandjbakhch F; Foltz V; Mallet A; Bourgeois P; Fautrel B
Ann Rheum Dis; 2011 Dec; 70(12):2159-62. PubMed ID: 21859693
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance imaging findings in 84 patients with early rheumatoid arthritis: bone marrow oedema predicts erosive progression.
Haavardsholm EA; Bøyesen P; Østergaard M; Schildvold A; Kvien TK
Ann Rheum Dis; 2008 Jun; 67(6):794-800. PubMed ID: 17981915
[TBL] [Abstract][Full Text] [Related]
19. Conventional versus ultrasound treat to target: no difference in magnetic resonance imaging inflammation or joint damage over 2 years in early rheumatoid arthritis.
Sundin U; Aga AB; Skare Ø; Nordberg LB; Uhlig T; Hammer HB; van der Heijde D; Kvien TK; Lillegraven S; Haavardsholm EA;
Rheumatology (Oxford); 2020 Sep; 59(9):2550-2555. PubMed ID: 31999341
[TBL] [Abstract][Full Text] [Related]
20. Modern treatment strategies in rheumatoid arthritis.
Hetland ML
Dan Med Bull; 2011 Nov; 58(11):B4320. PubMed ID: 22047935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
